Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Phase II Randomized Trial of Rituximab Plus Cyclophosphamide Followed by Belimumab for the Treatment of Lupus Nephritis

PaperCitations, authors & open-access status

Phase II Randomized Trial of Rituximab Plus Cyclophosphamide Followed by Belimumab for the Treatment of Lupus Nephritis is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 212 citations, 2020 year and hybrid oa status.

212
Citations
2020
Year
hybrid
OA Status

Related on ScholarIQ

David R. Karp
Author
Cynthia Aranow
Author
Maria Dall’Era
Author
Arthritis & Rheumatology
Journal
Systemic Lupus Erythematosus Research
Topic
Systemic Lupus Erythematosus Research
Topic
470M+ articles · free account